Who
Victor Edward Tong Jr.
Director
Company insider
Files Form 4 as: Director, Aardvark Therapeutics; Director, CG Oncology.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 4 Oct 2024
- Last trade
- 14 Aug 2026
- Last filed
- 21 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Aug 2026filed 21 Aug 2026 | AARD Aardvark Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,964 at $0.00 | filing |
| 14 Aug 2026filed 21 Aug 2026 | AARD Aardvark Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,964 at $0.00 | filing |
| 4 Jun 2026filed 5 Jun 2026 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,354 at $0.00 | filing |
| 4 Jun 2026filed 5 Jun 2026 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,354 at $0.00 | filing |
| 11 Jun 2025filed 13 Jun 2025 | AARD Aardvark Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —61,017 at $0.00 | filing |
| 5 Jun 2025filed 6 Jun 2025 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,165 at $0.00 | filing |
| 4 Oct 2024filed 7 Oct 2024 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,600 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.